Pharmos Corp Watch

from 10-K 3 pages (I) Pursuant to Section 2.7.1 of the Asset Purchase Agreement, the First Contingent Payment Shall Equal Twelve Million One Hundred Sixty Thousand Dollars ($12,160,000); (II) Pursuant to Section 6.7.2 of the Asset Purchase Agreement, Buyer Has Provided Seller With the Final Accounting of the Le-T R&D Costs Owed by Seller in the Amount of One Million Five Hundred Thirty Two Thousand Five Hundred Twenty Eight Dollars ($1,532,528), Which Amount Shall Be Credited to Buyer Against the First Contingent Payment at the Time the First Contingent Payment Is Paid; and (III) Seller and Buyer Agree That at the Payment Date, Buyer Will Remit the Sum of $1,337,600 to Dr. Nicholas Boder, Which Represents 11% of the Section 2.7.1 of the Asset Purchase Agreement First Contingent Payment. Seller Will Secure the Acknowledgement and Receipt (Exhibit 1) From Dr. Bodor and Transmit It to Buyer Prior to Buyer Releasing Any Funds

from 8-K ~50 pages Private Equity Line of Credit Agreement